Type | Public | |
Founded | 2011 | |
HQ | Bedminster, NJ, US | Map |
Website | matinasbiopharma.com | |
Overall Culture | D+ | More |
USD | |
---|---|
Revenue (Q3, 2020) | 95.8k |
Net income (Q3, 2020) | (5.4m) |
EBIT (Q3, 2020) | (5.6m) |
Market capitalization (8-Feb-2021) | 285.5m |
Closing stock price (8-Feb-2021) | 1.4 |
Cash (30-Sept-2020) | 7.1m |
EV | 282.3m |
USD | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 59.9k | 15.0k | 44.9k | 44.9k | 29.9k | 89.8k | 89.8k | 95.8k | |||||||||||||
General and administrative expense | 1.1m | 1.3m | 1.5m | 1.2m | 1.1m | 1.3m | 1.3m | 977.7k | 999.8k | 2.1m | 1.7m | 1.4m | 2.0m | 2.0m | 1.6m | 1.8m | 1.8m | 1.9m | 2.3m | 2.4m | 2.4m |
R&D expense | 1.1m | 1.1m | 1.1m | 1.4m | 1.4m | 879.2k | 921.7k | 642.6k | 835.3k | 2.4m | 2.3m | 2.0m | 2.2m | 1.5m | 1.4m | 2.3m | 2.8m | 2.7m | 4.1m | 3.4m | 3.3m |
Operating expense total | 2.1m | 2.4m | 2.6m | 2.6m | 2.5m | 2.2m | 2.2m | 1.6m | 1.8m | 4.5m | 4.0m | 3.5m | 4.2m | 3.5m | 3.0m | 4.1m | 4.6m | 4.6m | 6.3m | 5.8m | 5.7m |
USD | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash | 8.6m | 6.6m | 5.0m | 4.6m | 6.6m | 4.4m | 1.7m | 578.3k | 6.2m | 15.8m | 11.3m | 9.0m | 4.3m | 8.9m | 6.6m | 39.4m | 36.8m | 32.7m | 10.1m | 14.9m | 7.1m |
Accounts Receivable | 89.8k | ||||||||||||||||||||
Prepaid Expenses | 87.6k | 38.1k | 108.1k | 93.6k | 115.0k | 342.2k | 138.0k | 139.6k | 254.0k | 803.0k | 317.3k | 1.0m | 475.3k | 249.8k | 692.4k | 391.0k | 494.6k | 1.4m | 2.7m | 1.1m | 2.2m |
Current Assets | 8.6m | 6.7m | 5.1m | 4.8m | 6.9m | 4.9m | 1.9m | 773.5k | 6.5m | 16.8m | 11.7m | 10.2m | 4.9m | 9.3m | 7.5m | 39.9m | 37.4m | 34.3m | 74.0m | 69.2m | 65.2m |
USD | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | (2.1m) | (4.6m) | (7.2m) | (2.6m) | (5.0m) | (7.1m) | (2.2m) | (3.9m) | (5.7m) | (4.5m) | (8.5m) | (11.9m) | (4.1m) | (7.5m) | (10.5m) | (4.1m) | (7.4m) | (11.8m) | (5.0m) | (10.7m) | (16.1m) |
Depreciation and Amortization | 9.5k | 19.9k | 51.5k | 10.9k | 20.6k | 32.7k | 12.9k | 26.3k | 40.0k | 12.0k | 24.8k | 56.2k | 47.1k | 100.1k | 156.6k | 47.9k | 96.9k | 148.9k | 57.6k | 115.4k | 173.2k |
Accounts Payable | (154.4k) | (115.7k) | (184.9k) | (104.9k) | 174.0k | (289.5k) | 122.7k | (22.0k) | (288.4k) | 771.9k | (22.4k) | (134.0k) | (109.4k) | (85.5k) | (279.4k) | 99.0k | 252.5k | 390.1k | 274.0k | (184.7k) | (306.2k) |
Cash From Operating Activities | (2.1m) | (3.9m) | (5.5m) | (2.3m) | (4.5m) | (6.7m) | (1.5m) | (2.6m) | (4.0m) | (3.0m) | (6.8m) | (9.5m) | (2.8m) | (5.1m) | (7.7m) | (3.0m) | (5.1m) | (9.2m) | (4.7m) | (7.8m) | (13.1m) |
USD | Q1, 2014 |
---|---|
Financial Leverage | 1.1 x |
Matinas BioPharma has 6.4k Twitter Followers. The number of followers has increased 1% month over month and increased 4.7% quarter over quarter
1.3k
Tweets
2.1k
Following
6.4k
Followers
9
Tweets last 30 days
3.8
Avg. likes per Tweet
88.9%
Tweets with engagement
D+
63/100
C-
67/100
C-
62/100
D
60/100
When was Matinas BioPharma founded?
Matinas BioPharma was founded in 2011.
Who are Matinas BioPharma key executives?
Matinas BioPharma's key executives are Jerome D. Jabbour, Herbert Conrad and Theresa Matkovits.
How many employees does Matinas BioPharma have?
Matinas BioPharma has 21 employees.
What is Matinas BioPharma revenue?
Latest Matinas BioPharma annual revenue is $89.8 k.
What is Matinas BioPharma revenue per employee?
Latest Matinas BioPharma revenue per employee is $4.3 k.
Who are Matinas BioPharma competitors?
Competitors of Matinas BioPharma include Aimmune Therapeutics, Emisphere Technologies and Phio Pharmaceuticals.
Where is Matinas BioPharma headquarters?
Matinas BioPharma headquarters is located at 1545 US-206 #302, Bedminster.
Where are Matinas BioPharma offices?
Matinas BioPharma has offices in Bedminster and Raritan.
How many offices does Matinas BioPharma have?
Matinas BioPharma has 2 offices.
Receive alerts for 300+ data fields across thousands of companies